Children with sickle cell disease (SCD) have an increased incidence of severe Salmonella infections (5, 17) in addition to those infections caused by encapsulated bacteria ( I, 1 1, 15, 16). Functional asplenia, reticuloendothelial dysfunction, defective o~sonization abnormalities of the alternative pathway of complemeht activation, specific neutrophil dysfunction, tuftsin deficiency, and local host factors, such as thrombosis and infarction, have all been proposed as possible explanations for enhanced susceptibility to bicteiial infeciions (6). The study reported here was performed to evaluate the in vitro opsonization of Salmonella lipopolysaccharide (LPS) by sera from children with SCD by techniques not previously utilized in this group of patients. Attempts were made to clarify the function of the alternative pathway of complement activation in opsonization of Salmonella LPS and to relate the function of this system to predisposition to Salmonella infection, if any, in the child with SCD.
SCD patients included children who had had documented episodes of sepsis (3) . bacterial meningitis (2) , or chronic Salmonella osteomyelitis (I). Thirty-three well black children ( 13 females and 20 males) with a mean age of 8.9 years (range, 11 months to 17 years) provided control sera; of these children, seven had heterozygous AS or AC hemoglobin genotypes. All sera were obtained from children who were clinically free of infection at the time of venipuncture, but three children with SCD were in pain crisis at the time of venipuncture. Serum was frozen at -70°C within I hr collection. Human C2-deficient serum was donated by Dr. Michael Glovsky of the Kaiser Permanente Medical Center, Los Angeles, CA.
PHAGOCYTE PREPARATION A N D COLLECTION
Blood for phagocytes was obtained from patients hospitalized for a variety of acute and chronic infectious diseases on the'tos Angeles County-University of Southern California Medical Center Communicable Disease Service in National Institutes of Health anticoagulant formula 4 in a ratio of four parts blood to one part ant.coagulant. Leukocytes were collected by dextran sedimentation according to the method of Stossel (18) .
SERUM-DEPENDENT OPSONlZATlON OF SAl.MONE1.I.A enrenridis LPS
Time-fixed opsonization and phagocytosis. Opsonization ability of each individual serum was assessed by quantitation of ingestion of a LPS-parafin oil emulsion containing the dye oil red 0 (ORO) by phagocytes utilizing the technique of Stossel (18) with the single modication that S. enteritidis LPS (Difco Laboratories, Detroit, MI) was substituted for Escherichia coli LPS. All experiments were performed blind and in duplicate.
Preparation of Paraffin Oil LPS Emulsion. O R 0 (5 g) was dissolved in 50 ml of heavy paraffin oil (density, 0.89). After centrifugation, to remove undissolved dye, the optical density (O.D.) of the solution was read at 525 nm after dilution of 0.01 ml O R 0 solution with 10 ml dioxane; this permitted subsequent conversion of O.D. into mg of paraffin oil. T o prepare the final emulsion. Salmonella LPS [(lo mg/ml Krebs-Ringer phosphate (KRP)] was briefly sonicated. T o this mixture, the O R 0 solution was added in a ratio of 3.0 ml LPS to 1.0 ml of O R 0 solution. This mixture was then sonicated at 1.5 to 2 amps for 90 sec.
Opsonization. One-tenth ml (0.1) of ORO-LPS emulsion was dispensed into 15 ml conical, siliconized centrifuge tubes, and opsonization was initiated by the addition of an equal volume of serum (0. I ml); tubes were subsequently incubated at 37°C for 20 min with periodic gentle shaking. Opsonization was stopped by placing reaction tubes in ice.
Phagocytosis. Eight-tenths ml of the phagocytic cell suspension was dispensed to opsonized particles, and the mixture incubated at 37°C for 5 rnin with periodic gentle shaking. Ingestion was stopped by the addition of 6 ml of ice cold I mM N-ethylmaleimide in normal saline (N.S.). Reaction tubes were centrifuged, and the supernate, which contained undigested emulsion, was discarded. A second wash with N-ethylmaleimide was performed, and the tubes were manually cleaned and wiped dry with tissue. Solubilize ingested dye, one ml (1.0) of p-dioxane (J. T. Baker) was added to the cell pellet to lyse the leukocytes. After lysis of leukocytes and subsequent centrifugation, the supernatant O.D. was read at 525 nm. For initial rates of ingestion, results were expressed as mg of parafin oil ingested per 10' Control experiments with O R 0 dyes, without added LPS, repeatedly failed to reveal uptake of dye microscopically; O R 0 without LPS was included as a control with each experiment. Also, heat-treated normal serum was included as a control for each experiment.
Kinetics of Opsonization. To measure the kinetics of opsonization. 0.8 ml of ice cold serum was added to 0.8 ml of ice-cold emulsion in 30 ml round-bottomed centrifuge tubes. Before placement of the emulsion-serum mixture in a 37°C water bath, 0.2 ml aliquots were removed for "0" time samples and placed into t 5 ml conical centrifuge tubes. After 5, 10, 20, 40 , and 75 min of incubation at 37°C. additional 0.2 ml aliquots were removed and also placed into iced centrifuge tubes. All samples were run in duplicate. Phagocytosis was performed identically to the timefixed opsonization.
Sensitivity and Precision of the Opsonization Assay. T o determine the sensitivity of the assay, serum was sequentially diluted with Krebs-Ringer phosphate, and opsonization and subsequent phagocytosis were performed on the various dilutions of serum, by the methods described. To determine the assay variation, the opsonization ability of a single serum sample was repetitively determined nine and ten times on two separate occasions; the coeflicient of variation was determined by standard methods.
Role of Complement and Antibody in Opsonization. Assay for
Hemagglutination ( H A ) Antibody to S. enteritidis LPS. Antibody against LPS was measured by a microhemagglutination technique using sheep RBC's (8) . Before determination of antibody titers, all sera were preabsorbed for 2 hr at room temperature with an equal volume of a 1Wo suspension of uncoated SRBC's. The antibody titer of each serum was determined utilizing both LPS coated and uncoated SRBC's, and the final titer was recorded as the difference between the two titers, with final titers expressed as the highest serum dilutions resulting in agglutination.
Preparation of S. enteritidis L P S Immune Serum. S. enteritidis
LPS ( 1 pg/ml) was suspended in KRP, sonicated, and passed through a 45-micron Millipore filter. Two rabbits received five successively increasing daily doses of LPS (0.33 to 1.7 pg). On the eighth day after the last dose, the rabbits were bled, and the sera was stored at -20°C.
Complement Consumption Studies. The ability of S. enteritidis LPS to initiate complement consumption was evaluated in five SCD patients and five control subjects. Two children selected from each group had high anti-LPS titers (21:64), and two had low antibody titers (51:4); one from each group had intermediate titers. Equal volumes of each tested serum sample plus either LPS (7.5 mg/ml) in KRP or KRP alone were incubated at 37°C for 20 rnin. The solutions were then cooled to O°C, and dilutions were made in veronal buffered saline-glucose buffer (14) . Determinations of CI, C2, C3, and C4 activity were made by previously published methods (10. 12. 14). Factor B conversion was evaluated by immunoelectrophoresis using monospecific goat anti-factor B (Atlantic Antibodies, Westbrook, MN). When calculating the results, the value of the serum KRP mixture was defined as 100%.
Ability of Complement-Depleted Serum to Support Opsonization.
Human congenital C2-deficient serum and serum heated to 50°C for 20 min, to inactivate factor / I , were opsonized and phagocytosized as described. Normal human serum with an HA titer of I: 64 to S. enteritidis LPS was depleted o f both C4 and factor B by passage through an Fab immunoabsorbant column in the presence of 10 mM EDTA (Courtesy of Robert Schreiber, M.D., Scripps Clinic, La Jolla, CA). Serum was reconstituted with a solution of 1:5 mM CaCI2 in N.S. Opsonization ability and phagocytosis were compared as described in untreated. EDTA, and heat-treated (50°C x 20 min) and reconstituted aliquots as well as aliquots not reconstituted.
RESULTS

OPSONIZATION
Sensitivity and Precision of Assay.
Opsonization in sequentially diluted serum demonstrated a direct linear relationship between the amount of LPS-paraffin oil emulsion ingested and serum dilution (Fig. 1) . The calculated coefficient of variation for the assay varied from 4 to 13%.
TIME-FIXED OPSONIZATION
The results of time-fmed (20 min) opsonization studies are displayed in Figures 2 and 3 . There were no detectable differences in the ability of sera to support opsonization between children with SCD and normal children, including children with AC or AS genotypes. Because of interassay variation, results are expressed as mg of paraffin oil ingested per lo7 phagocyies per min (Fig. 2) as well as the percentage of variation of each individual serum sample from the control group mean which was determined for each experiment (Fig. 3) . For SCD patients, the quantitative opsonization values were from 0.110 to 0.201 mg of paraffin oil 
KINETICS OF OPSONlZATlON
No differences were noted in the kinetics of opsonization between three pairs of children evaluated (i.e., control child versus SCD child). A representative curve from one of these pairs of children is depicted in Figure 4 . Maximal ingestion was attained 
Time (minutes)
between 10 and 15 min of incubation in both SCD and normal children.
COMPLEMENT AND ANTIBODY STUDIES
H A Antibody Titers to S, enteritidis LPS. Twenty-five SCD sera and 27 control sera were evaluated for the presence of HA antibody to the LPS. The median titer for the SCD sera was 1:8 (range. 1:4 to 1:32); control sera also had median titers of 1:8 (range, 1:4 to 1:64). There was no correlation between HA titer and the ability to opsonize Salmonella LPS (Fig. 5) .
COMPLEMENT CONSUMPTION BY LPS
The effect of LPS on the consumption of the first four components of complement and factor B was evaluated after incubation of serum with Salmonella LPS or buffer control at 37°C for 20 min (Table 1) . Under these conditions, Salmonella LPS induced a mean consumption of 0.2% of CI, 1. I% of C4, 19.2% of C2, and 84.6% of C3 in control and SCD sera. All serum samples had almost total conversion of factor B as determined by visual inspection of the immunoelectrophoretic pattern. There was no correlation between Salmonella HA titers and complement consumption. Further, there were no major differences in complement consumption between the SCD group and control subjects, although there was a trend toward slightly greater C2 consumption in the latter group. Human serum congenitally deficient in C2 supported opsonization normally, with values of 75 to 95% of control. Three sera immunologically depleted of factor B or heated (50°C for 20 min) resulted in marked impairment of opsonization, whereas sera depleted of C4 opsonized normally. Table 2 displays a representative result against a single sera.
DISCUSSION
In this study, no defect in opsonization of S. enteritidis LPS could be detected in the sera of patients with SCD using an assay which appears to be mediated predominantly via the alternative pathway of complement activation. This assumption is supported by the demonstration of normal opsonization in human C2-deficient serum as well as serum depleted of C2 and C4, whereas serum depleted of factor B and heated serum resulted in marked impairment of opsonization. Our observations on changes of complement factors (Table I ) during opsonization may be limited by the relatively few number of sera included in these experiments. HA titers against Salmonella LPS in sera tested were low; there were no differences in HA titers between SCD and control sera, and no correlation was found between HA titers and the ability of a serum to support opsonization. The observation of a marked consumption of C3, in association with factor B conversion and relative sparing of the early complement components (C 1, C4, and C2), adds further evidence of the dependence of this assay on the alternative pathway. These findings are in accord with the work of Stossel (18) who demonstrated that C2-and C4-deficient sera supported normal opsonization of E. coli LPS whereas C3-deficient and cord blood sera (i.e., factor B deficient) failed to support normal opsonization; defects in opsonization could be restored by the addition of the deficient components. Only in the presence of hyperimmune sera was he able to demonstrate a modest increase in the ability to support opsonization. The finding of normal opsonization of Salmonella LPS in this group is consistent with the work of Winkelstein and Drachman (22) who detected no defect in opsonization of Salmonella choleraesuis in the evaluation of a small group of patients with SCD using an assay similar to the one in which he observed defective opsonization of Streptococcus pneumoniae. However, these experiments are in contrast to the results noted by Hand and King (4) who reported defective opsonization of Salmonella. This discrepancy may be due in part to differences in design of the two studies. In the studies reported here, S. enteritidis LPS was utilized for opsonization in contrast to that of viable Salmonella typhimurium which was used by Hand and King (4) . The use of viable organisms necessitates the quantitation of ingestion of microorganisms indirectly by enumerating the number of bacteria left in extracellular compartment after phagocytosis. Unfortunately, this may subject the results of such experiments to influences that affect the bacteria other than opsonization such as the interaction with undefined serum factors. Serum factors may directly affect bacterial viability, and in the experiments cited by Hand and King, operation of these undefined factors was suggested by the observation that a wncentration of 5% serum in the absence of phagocytes resulted in a 50% reduction in viable organisms (4) . In contrast to these observations, the same investigators have reported defective killing of S. ryphimurium in the absence of phagocytosis by SCD sera in a separate report (3) . Lastly, dependence on colony counts of viable organisms to quantitate phagocytosis may influence the outcome of experiments due to the intrinsic lack of quantitative precision of microbiologic colony counting which is influenced by many variables (13) .
The kinetics of opsonization were evaluated in our studies to test the possibility that children with SCD may opsonize at a different rate than do normal children. In the three patients studied, no differences were noted when compared to normal children. In each, opsonization reached a peak after 15 min of incubation with serum and plateaued or slowly declined thereafter. Due to the complexity of these experiments, only three SCD were studied; however, kinetic curves are similar to those constructed by Stossel (18) using E. coli LPS in normal patients.
Although defects in pneumococcal opsonization have been consistently noted in some patients with SCD (2, 4, 22) , this has not been true for gram-negative organisms (2, 22) . This suggests that patients with SCD may have a selective opsonization defect, and the explanation for their increased susceptibility towards Salmonella infection may be different than that for the pneumococcus. The precise nature of the defect in pneumococcal opsonization has not been defined, although it has been suggested that there is defective functioning of the alternative pathway. Bjornson et al. (2) noted that total hemolytic complement, conversion of C3 by inulin or CoVF, and immunochemical measurements of serum levels of factor B, properdin, C3b inactivator, and immunoglobulins were normal in children with SCD; the wncentration of C3 was slightly reduced, a finding which did not correlate with reduced opsonization. Koethe et al. (8) found reduced activation of complement by CoVF in SCD sera while factor B levels were normal or elevated, suggesting that these patients have reduced factor D activity. Wilson et al. (21) measured factors B and D using a functional hemolytic radial diffusion assay and noted a subgroup of patients with low alternative pathway activity associated with low levels of factor B and normal levels of factor D.
Our study suggests that opsonization of Salmonella LPS is mediated predominantly via the alternative pathway and that in the SCD children evaluated, no abnormalities were detected. The reasons for such diversity of results between reported studies remain unclear; however, in part, the explanation may be related to an incomplete understanding of the complexities of the involved immunologic pathways as well as its interaction with other serum proteins such as antibody, CRP, other complement wmponents, or as yet undefined pathways or factors. Further, it may be that the alternative pathway is quantitatively more important in pneumococcal infections, and therefore, small defects are more apparent in vitro. The available evidence to date suggests that if the patient with SCD does have a defect in the function of the alternative pathway, it is probably a minor determinant in his propensity toward Salmonella infections.
